Crop Life Science Ltd Stock Price Today (NSE: CLSL)
Fundamental Score
Crop Life Science Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Crop Life Science Ltd share price today is ₹48.70, up +0.00% on NSE/BSE as of 19 February 2026. Crop Life Science Ltd (CLSL) is a Small-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of ₹89.13 (Cr). The 52-week high for CLSL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 14.40x, CLSL is currently trading below its industry average P/E of 29.36x. The company has a Return on Equity (ROE) of 8.83% and a debt-to-equity ratio of 0.72.
Crop Life Science Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Crop Life Science Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Crop Life Science Share Price
The pesticides and agrochemicals industry is experiencing a period of nuanced growth, driven by increasing demand for food security coupled with heightened environmental concerns prompting innovation in sustainable solutions. This analysis examines the financial stability of Crop Life Science Ltd, focusing on its current market position. The current share price of Crop Life Science is ₹49.5, with a Price-to-Earnings (PE) ratio of 14.4 and a Return on Capital Employed (ROCE) of 12.06%. This assessment is part of a broader 80-parameter fundamental audit, verified by Sweta Mishra, designed to provide a comprehensive overview of the company’s financial health.
A crucial metric for evaluating a company's attractiveness is its PE ratio. Crop Life Science's PE of 14.4 suggests that investors are paying ₹14.4 for every rupee of earnings. Comparing this to its peers provides valuable insights. For instance, assessing the management quality of a peer such as
Phyto Chem India Limited and then contrasting it with Crop Life Science Ltd's management track record can reveal potential strengths or weaknesses in operational efficiency and strategic decision-making.The ROCE of 12.06% indicates the company's efficiency in generating profits from its capital employed. This metric is particularly relevant when assessing the company's moat or competitive advantage. A consistently high ROCE, exceeding the cost of capital, suggests that the company possesses a strong ability to generate superior returns and maintain its market position. The 12.06% return, if consistently maintained or improved, can act as a barrier to entry for competitors, reinforcing Crop Life Science's competitive advantage in the agrochemicals sector. However, sustaining this level of return requires continued innovation, efficient cost management, and effective market penetration.
Further analysis should focus on examining Crop Life Science's debt levels, cash flow generation, and future growth prospects relative to its peers like Mol Hungarian Oil and Gas Public Limited Company and Bharat Rasayan Ltd. A detailed comparison of these factors would provide a more comprehensive understanding of the risks and opportunities associated with an investment in Crop Life Science share price. This analysis uses observational language and does not offer any buy or sell recommendations.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Crop Life Science Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CLSL across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Attractive Valuation (P/E: 14.40 vs Industry: 29.36)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Profit Growth Track Record (15.43% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (70.01%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
4 factors identified
Below-Average Return on Equity (8.83%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-12.50%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-22.44 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Crop Life Science Ltd Financial Statements
Comprehensive financial data for Crop Life Science Ltd including income statement, balance sheet and cash flow
About CLSL (Crop Life Science Ltd)
Crop Life Science Ltd (CLSL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pesticides & Agrochemicals sector with a current market capitalisation of ₹89.13 (Cr). Crop Life Science Ltd has delivered a Return on Equity (ROE) of 8.83% and a ROCE of 12.06%. The debt-to-equity ratio stands at 0.72, reflecting the company's capital structure. Investors tracking CLSL share price can monitor key metrics including P/E ratio, promoter holding of 70.01%, and quarterly earnings growth.
Company Details
CLSL Share Price: Frequently Asked Questions
What is the current share price of Crop Life Science Ltd (CLSL)?
As of 19 Feb 2026, 06:16 am IST, Crop Life Science Ltd share price is ₹48.70. The CLSL stock has a market capitalisation of ₹89.13 (Cr) on NSE/BSE.
Is CLSL share price Overvalued or Undervalued?
CLSL share price is currently trading at a P/E ratio of 14.40x, compared to the industry average of 29.36x. Based on this relative valuation, the Crop Life Science Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of CLSL share price?
The 52-week high of CLSL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Crop Life Science Ltd share price?
Key factors influencing CLSL share price include quarterly earnings growth (Sales Growth: 13.11%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Crop Life Science Ltd a good stock for long-term investment?
Crop Life Science Ltd shows a 5-year Profit Growth of 15.43% and an ROE of 8.83%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.72 before investing in CLSL shares.
How does Crop Life Science Ltd compare with its industry peers?
Crop Life Science Ltd competes with major peers in the Pesticides & Agrochemicals. Investors should compare CLSL share price P/E of 14.40x and ROE of 8.83% against the industry averages to determine competitive standing.
What is the P/E ratio of CLSL and what does it mean?
CLSL share price has a P/E ratio of 14.40x compared to the industry average of 29.36x. Investors pay ₹14 for every ₹1 of annual earnings.
How is CLSL performing according to Bull Run's analysis?
CLSL has a Bull Run fundamental score of 39.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does CLSL belong to?
CLSL operates in the Pesticides & Agrochemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Crop Life Science Ltd share price.
What is Return on Equity (ROE) and why is it important for CLSL?
CLSL has an ROE of 8.83%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Crop Life Science Ltd generates profits from shareholders capital.
How is CLSL debt-to-equity ratio and what does it indicate?
CLSL has a debt-to-equity ratio of 0.72, which indicates moderate leverage that should be monitored.
What is CLSL dividend yield and is it a good dividend stock?
CLSL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Crop Life Science Ltd shares.
How has CLSL share price grown over the past 5 years?
CLSL has achieved 5-year growth rates of: Sales Growth 9.28%, Profit Growth 15.43%, and EPS Growth 7.49%.
What is the promoter holding in CLSL and why does it matter?
Promoters hold 70.01% of CLSL shares, with 2.08% pledged. High promoter holding often indicates strong management confidence in Crop Life Science Ltd.
What is CLSL market capitalisation category?
CLSL has a market capitalisation of ₹89 crores, placing it in the Small-cap category.
How volatile is CLSL stock?
CLSL has a beta of N/A. A beta > 1 suggests the Crop Life Science Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is CLSL operating profit margin trend?
CLSL has a 5-year average Operating Profit Margin (OPM) of 7.91%, indicating the company's operational efficiency.
How is CLSL quarterly performance?
Recent quarterly performance shows Crop Life Science Ltd YoY Sales Growth of 13.11% and YoY Profit Growth of -12.50%.
What is the institutional holding pattern in CLSL?
CLSL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Crop Life Science Ltd stock.